medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2023, Number 09

<< Back Next >>

Ginecol Obstet Mex 2023; 91 (09)

Treatment of overactive bladder syndrome by bilateral transcutaneous posterior tibial nerve stimulation

Rodríguez LR, Montiel MRI, Granados MV, Gorbea CV, Ramírez IC

Language: Spanish
References: 18
Page: 653-659
PDF size: 186.00 Kb.


ABSTRACT

Objective: To determine whether bilateral transcutaneous stimulation of the posterior tibial nerve reduces symptoms of overactive bladder and improves quality of life.
Materials and Methods: Simple, retrospective, cohort study carried out in patients attended at the gynaecological urology clinic of the Instituto Nacional de Perinatología Isidro Espinosa de los Reyes in Mexico City, from 8 October 2021 to 14 July 2022 to whom bilateral transcutaneous electrostimulation therapy of the posterior tibial nerve was applied to treat overactive bladder syndrome. Study parameters: severity, quality of life and voiding diary in sessions 1, 6 and 12. Descriptive statistics and paired t-test were used for comparison at baseline and at the end of treatment; p ‹ 0.05 was considered statistically significant.
Results: Twenty-five patients were studied: 23 with a decrease in King's Health quality of life score of 24.5 between sessions 1 and 12 (p ‹ 0.001). The decrease in symptom severity score (OABSS) was 16.6 between sessions 1 and 12 (p ‹ 0.001). Significant improvement was observed in all voiding diary parameters.
Conclusion: In this sample, bilateral transcutaneous posterior tibial nerve stimulation significantly decreased overactive bladder symptoms and improved quality of life.


REFERENCES

  1. Haylen BT, Ridder D, Freeman R, Swift S, Berghmans B,Lee J, et al. An International Urogynecological Association(IUGA) / Internacional Continence Society (ICS) Joint Reporton the Terminology for Female Pelvic Floor Dysfunction.Neurourol Urodynam 2010; 29: 4-20. https://doi.org/10.1002/nau.20798

  2. Vecchioli-Scaldazza C, Morosetti C. Effectiveness and durabilityof solifenacin versus percutaneous tibial nerve stimulationversus their combination for the treatment of women withoveractive bladder syndrome: a randomized controlled studywith a follow-up of ten months. Int Braz J Urol 2018; 44:102-108. https://doi.org/10.1590/S1677-5538.IBJU.2016.0611

  3. Booth J, Connelly L, Dickson S, Duncan F, Lawrence M. Theeffectiveness of transcutaneous tibial nerve stimulation(TTNS) for adults with overactive bladder syndrome: Asystematic review. Neurourol Urodynam 2018; 37: 528-41.https://doi.org/10.1002/nau.23351

  4. Lightner DJ, Gomelsky A, Souter L, Vasavada S. Diagnosisand Treatment of Overactive Bladder (Non-Neurogenic)in Adults: AUA/SUFU Guideline Amendment 2019. J Urol2019; 202: 558-63. doi:10.1097/JU.0000000000000309

  5. Arnold J, McLeod N, Thani R, Rashid P. Overactive BladderSyndrome: Management and Treatment Options. Aust FamPhysician 2012; 41: 878-83. PMID: 23145420

  6. Peyronnet B, Mironska E, Chapple C, Cardozo L, Oekle M,Dmochowski R, et al. A Comprehensive Review of OveractiveBladder Pathophysiology: On the Way to TailoredTreatment. Eur Urol 2019; 75: 988-1000. https://doi.org/10.1016/j.eururo.2019.02.038

  7. Gamble T, Du H, Sand P, Botros S, Rurak M, Goldberg R. Urgeincontinence: estimating environmental and obstetrical riskfactors using an identical twin Study. Int Urogyencol J 2010;21: 939-46. doi:10.1007/s00192-010-1140-2

  8. Leron E, Weintraub AY, Mastrolia S, Schwarzman P. Overactivebladder syndrome: evaluation and management. CurrUrol 2017; 11: 117-25. doi:10.1159/000447205

  9. Bo K, Berghmans B, Morkyed S, Van Kampen M. Evidence-Based Physical Therapy for the Pelvic Floor: Bridging Scienceand Clinical Practice, 2007.

  10. Staskin D, Peters K, MacDiarmid S, Shore N, de Groat W.Percutaneous tibial nerve stimulation: A clinically andcost-effective addition to the overactive bladder algorithmof care. Curr Urol Rep 2012; 13: 227-334. doi: 10.1007/s11934-012-0274-9

  11. Ramírez-Garcia I, Blanco-Ratto L, Kauffman S, Carralero-Martinez A, Sanchez E. Efficacy of transcutaneous stimulationof the posterior tibial nerve compared to percutaneousstimulation in idiopathic overactive bladder syndrome:Randomized control trial. Neurourol Urodyn 2019; 38:261-68. doi: 10.1002/nau.23843

  12. Thomas GP, Dudding TC, Nicholls RJ, Vaizey C. BilateralTranscutaneous Posterior Tibial Nerve Stimulation for theTreatment of Fecal Incontinence. Dis Colon Rectum 2013;56: 1075-79. doi: 10.1097/DCR.0b013e31829bf940

  13. Blaivas J, Panagopoulos G, Weiss J, Somaroo C. Validationof the overactive bladder symptom score. J Urol 2007; 128:543-7. doi: 10.1016/j.juro.2007.03.133

  14. Kelleher C, Cardozo L, Khullar V, Salvatorre S. A new questionnaireto assess the quality of life of urinary incontinentwomen. BJOG 1997; 104: 1374-79. doi: 10.1111/j.1471-0528.1997.tb11006.x

  15. Badia L, Castro D, Conejero J. Validez del cuestionarioKing´s Health para la evaluación de la calidad de vidaen pacientes con incontinencia urinaria. Med Clin (Barc)2000; 17: 647-52. https://doi.org/10.1016/S0025-7753(00)71390-X

  16. Yang DY, Zhao LN, Qiu MX. Treatment for OveractiveBladder: A meta-analysis of transcutaneous tibial nervestimulation versus percutaneous tibial nerve stimulation.Medicine 2021; 100: e25941. doi: 10.1097/MD.0000000000025941

  17. Martin-Garcia M, Trochez RD. Effectiveness of bilateralpercutaneous posterior tibial nerve stimulation for womenwith idiopathic overactive bladder. POGP 2017; 121: 53-58.

  18. Linhares M, Friso B, Aparecida R, Milhem J, Chada E,Gonçalves E. Comparison of transcutaneous electricaltibial nerve stimulation for the treatment of overactivebladder: a multi-arm randomized controlled trial withblinded assessment. Clinics 2021; 76: e3039. doi: 10.6061/clinics/2021/e3039




2020     |     www.medigraphic.com